Skip to main content
. 2012 Sep 11;4(6):1039–1044. doi: 10.3892/etm.2012.704

Table V.

Combined vacA, cagA, iceA genotypes.

Clinical status
Combination GUa n (%) GSb n (%) GCc n (%) Total n (%)
s1am2/cagA+/iceA1 1 (1.5) 2 (4.1) 0 (0.0) 3 (1.8)
s1am2/cagA/iceA1 2 (2.9) 0 (0.0) 0 (0.0) 2 (1.2)
s1am2/cagA+/iceA2 1 (1.5) 0 (0.0) 0 (0.0) 1 (0.6)
s1bm2/cagA+/iceA1 0 (0.0) 0 (0.0) 3 (6.0) 3 (1.8)
s1bm2/cagA/iceA1 0 (0.0) 0 (0.0) 2 (4.0) 2 (1.2)
s1cm1/cagA+/iceA1 10 (14.3) 2 (4.1) 0 (0.0) 12 (7.1)
s1cm1/cagA/iceA1 2 (2.9) 0 (0.0) 0 (0.0) 2 (1.2)
s1cm1/cagA+/iceA2 4 (5.8) 2 (4.1) 0 (0.0) 6 (3.6)
s1cm2/cagA+/iceA1 40 (58.0) 23 (47.0) 32 (64.0) 95 (56.5)
s1cm2/cagA/iceA1 2 (2.9) 1 (2.0) 2 (4.0) 5 (3.0)
s1cm2/cagA+/iceA2 6 (8.7) 18 (36.7) 11 (22.0) 35 (20.8)
s1cm2/cagA/iceA2 1 (1.5) 1 (2.0) 0 (0.0) 2 (1.2)
Total 69 (100) 49 (100) 50 (100) 168 (100)
a

gastric ulcer;

b

gastritis;

c

gastric cancer. Twenty-nine patients with mixed infection were excluded.